Literature DB >> 36262639

Understanding Obesity-Related High Output Heart Failure and Its Implications.

Qiuhua Shen1, John B Hiebert1, Faith K Rahman1, Kathryn J Krueger1, Bhanu Gupta2, Janet D Pierce1.   

Abstract

Morbid obesity remains most common cause of high output failure. The prevalence of the obesity is growing when two-thirds of American adults already are overweight or obese. Obesity is the risk factor for heart disease and eventually leads to heart failure. High output heart failure is common in obese patients and is characterized by high cardiac output, decreased systemic vascular resistance, and increased oxygen consumption. It often occurs in patients with chronic severe anemia, hyperthyroidism, pregnancy, arterial-venous fistulas, and liver disease. However, the pathogenesis of obesity-related high output heart failure is not fully understood. The clinical management of obesity-related high output heart failure follows conventional heart failure regimens due to lack of specific clinical recommendations. This article reviews the possible pathophysiological mechanisms and causes that contribute to obesity-related high output heart failure. This review also focuses on the implications for clinical practice and future research involved with omics technologies to explore possible molecular pathways associated with obesity-related high output heart failure.
Copyright © 2021. Korean Society of Heart Failure.

Entities:  

Keywords:  Adipokines; Etiology; Genomics; Heart failure; Obesity

Year:  2021        PMID: 36262639      PMCID: PMC9536652          DOI: 10.36628/ijhf.2020.0047

Source DB:  PubMed          Journal:  Int J Heart Fail        ISSN: 2636-154X


  73 in total

1.  Leptin induces elongation of cardiac myocytes and causes eccentric left ventricular dilatation with compensation.

Authors:  Yukiko Abe; Koh Ono; Teruhisa Kawamura; Hiromichi Wada; Toru Kita; Akira Shimatsu; Koji Hasegawa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-01-12       Impact factor: 4.733

2.  The role of sodium in the production of edema.

Authors:  J P PETERS
Journal:  N Engl J Med       Date:  1948-09-02       Impact factor: 91.245

3.  Cardiopulmonary exercise testing as a diagnostic tool for the detection of left-sided pulmonary hypertension in heart failure.

Authors:  Marco Guazzi; Lawrence P Cahalin; Ross Arena
Journal:  J Card Fail       Date:  2013-07       Impact factor: 5.712

4.  Association of body mass index and diastolic function in metabolically healthy obese with preserved ejection fraction.

Authors:  Zach Rozenbaum; Yan Topilsky; Shafik Khoury; David Pereg; Michal Laufer-Perl
Journal:  Int J Cardiol       Date:  2018-08-04       Impact factor: 4.164

5.  Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients.

Authors:  Gino Seravalle; Manuela Colombo; Paolo Perego; Vittorio Giardini; Marco Volpe; Raffaella Dell'Oro; Giuseppe Mancia; Guido Grassi
Journal:  Hypertension       Date:  2014-05-27       Impact factor: 10.190

Review 6.  Obesity and hypertension.

Authors:  Gino Seravalle; Guido Grassi
Journal:  Pharmacol Res       Date:  2017-05-19       Impact factor: 7.658

Review 7.  Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.

Authors:  Barry A Borlaug; Walter J Paulus
Journal:  Eur Heart J       Date:  2010-12-07       Impact factor: 29.983

8.  Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018.

Authors:  Craig M Hales; Margaret D Carroll; Cheryl D Fryar; Cynthia L Ogden
Journal:  NCHS Data Brief       Date:  2020-02

9.  Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system.

Authors:  Kevin M Pantalone; Todd M Hobbs; Kevin M Chagin; Sheldon X Kong; Brian J Wells; Michael W Kattan; Jonathan Bouchard; Brian Sakurada; Alex Milinovich; Wayne Weng; Janine Bauman; Anita D Misra-Hebert; Robert S Zimmerman; Bartolome Burguera
Journal:  BMJ Open       Date:  2017-11-16       Impact factor: 2.692

Review 10.  Genetics and genomics of dilated cardiomyopathy and systolic heart failure.

Authors:  Upasana Tayal; Sanjay Prasad; Stuart A Cook
Journal:  Genome Med       Date:  2017-02-22       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.